Table 1. Characteristics of the patients enrolled in the clinical trial.

Characteristics	Treatment (n, %)	Placebo (n, %)	P
Sex
Female (n, %)	42 (55.3)	46 (59)	0.64
Male (n, %)	34 (44.7)	32 (41)
Ethnicity
AIAN/NHPI (n, %)	2 (2.6)	0	0.81
Asian (n, %)	7 (9.2)	11 (14.1)
Black (n, %)	18 (23.7)	15 (19.2)
White (n, %)	46 (60.5)	48 (61.5)
Multiple (n, %)	3 (3.9)	4 (5.1)
Age (years)
Mean (SD)	17.2 (16.6)	16.8 (16.5)	0.88
Median	12	12	1.0
Range	2–70	2–69
2–11 year olds (n, %)	37 (48.7)	38 (48.7)	1.0
12–17 year olds (n, %)	22 (28.9)	23 (29.5)
>18 years (n, %)	17 (22.4)	17 (21.8)
Severity
IGA 2 (n, %)	10 (13.2)	12 (15.4)	0.69
IGA 3 (n, %)	66 (86.8)	66 (84.6)
EASI (mean, SD)	10.2 (3.66)	9.6 (3.9)	0.33
BSA (mean, SD)	13.4 (7.59)	12 (7.09)	0.23
Pruritus NRS (mean, SD)	5.3 (2.09)	5.3 (2.18)	1.0
POEMS (mean, SD)	13.5 (6.63)	13.4 (6.39)	0.92